Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Formula: C9H17N4O9P
5)31(34)23(17-36(25
and is mainly used in the treatment of asthma and stroke
It causes growth inhibition of normal and transformed cells but does not induce cell death
AVL-292 Catalog No.:M11333-2 Formula: C9H17N4O9PSpebrutinib, also known as AVL 292 or CC 292, is an orally bioavailable, selective inhibitor of Brutons agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity. Upon administration, AVL 292 targets and covalently binds to BTK, thereby preventing its activity. By irreversibly inhibiting BTK, administration of this agent may lead to an inhibition of B cell receptor (BCR) signaling and may inhibit cell proliferation of B cell
US$ 12.99
US$ 29.99
US$ 5771.06
US$ 17.05